A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain

Journal of Pain

Volumn 6, Issue 10, 2005, Pages 656-661

  Katz, Jennifer ^a,b   Pennella Vaughan, Janet ^a   Hetzel, Roderick D ^c   Kanazi, Ghassan E ^d   Dworkin, Robert H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c BAYLOR UNIVERSITY   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Antidepressant medication; Bupropion; Low back pain; Randomized clinical trial

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; PLACEBO;

ADULT; ANALGESIA; ANOREXIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DISEASE EXACERBATION; DOPAMINE UPTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; EMPHYSEMA; FEMALE; HUMAN; HYPERHIDROSIS; INSOMNIA; LIBIDO DISORDER; LOW BACK PAIN; MALE; MICTURITION DISORDER; NEUROPATHIC PAIN; NORADRENALIN UPTAKE; NORADRENERGIC SYSTEM; PATIENT SATISFACTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECTUM HEMORRHAGE; RESTLESSNESS; SAMPLE SIZE; SEROTONINERGIC SYSTEM; SIDE EFFECT; SUSTAINED DRUG RELEASE; TACHYCARDIA; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CHRONIC DISEASE; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOPAMINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; NEURALGIA; NOREPINEPHRINE; PAIN MEASUREMENT; PAIN THRESHOLD; PAIN, INTRACTABLE; PLACEBOS; TREATMENT FAILURE;

EID: 25844512683     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2005.05.002     Document Type: Article

References (17)

1. G.B.J. Andersson Epidemiologic features of chronic low back pain Lancet 354 1999 581 585
2. J.A. Ascher, J.O. Cole, J.N. Colin, J.P. Feighner, R.M. Ferris, H.C. Fibiger, R.N. Golden, P. Martin, W.Z. Potter, E. Richelson, F. Sulser Bupropion a review of its mechanism of antidepressant activity J Clin Psychiatry 56 1995 395 401
3. J.H. Atkinson, M.A. Slater, D.R. Wahlgren, R.A. Williams, S. Zisook, S.D. Pruitt, J.E. Epping-Jordan, T.L. Patterson, I. Grant, I. Abramson, S.R. Garfin Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity Pain 83 1999 137 145
4. J.H. Atkinson, M.A. Slater, D.R. Wahlgren, R.A. Williams, S. Zisook, S.D. Pruitt, J.E. Epping-Jordan, T.L. Patterson, I. Grant, I. Abramson, S.R. Garfin A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain Pain 76 1998 287 296
5. M. Backonja, A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. LaMoreaux, E. Garofalo Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus JAMA 280 1998 1831 1836
6. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, J. Erbaugh An inventory for measuring depression Arch Gen Psychiatry 4 1961 561 571
7. J. Cohen Statistical Power Analysis for the Behavioral Sciences 1988 Lawrence Erlbaum Hillsdale, NJ
8. R.H. Dworkin, A.E. Corbin, J.P. Young Jr, U. Sharma, L. LaMoreaux, H. Bockbrader, E.A. Garofalo, R.M. Poole Pregabalin for the treatment of postherpetic neuralgia a randomized, placebo-controlled trial Neurology 60 2003 1274 1283
9. R.H. Dworkin, D.C. Turk, J.T. Farrar, J.A. Haythornthwaite, M.P. Jensen, N.P. Katz, R.D. Kerns, G. Stucki, R.R. Allen, N. Bellamy, D.B. Carr, J. Chandler, P. Cowan, R. Dionne, B.S. Galer, S. Hertz, A.R. Jadad, L.D. Kramer, D.C. Manning, S. Martin, C.G. McCormick, M.P. McDermott, P. McGrath, S. Quessy, B.A. Rappaport, W. Robbins, J.P. Robinson, M. Rothman, M.A. Royal, L. Simon, J.W. Stauffer, W. Stein, J. Tollett, J. Wernicke, J. Witter Core outcome measures for chronic pain clinical trials IMMPACT recommendations Pain 113 2005 9 19
10. J.T. Farrar, J.P. Young Jr, L. LaMoreaux, J.L. Werth, R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158
11. M.B. Max, S.A. Lynch, J. Muir, S.E. Shoaf, B. Smoller, R. Dubner Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy N Engl J Med 326 1992 1250 1256
12. R. Melzack The McGill Pain Questionnaire major properties and scoring methods Pain 1 1975 277 299
13. S.M. Salerno, R. Browning, J.L. Jackson The effect of antidepressant treatment on chronic back pain a meta analysis Arch Intern Med 62 2002 19 23
14. T.J. Schnitzer, A. Ferraro, E. Hunsche, S.X. Kong A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain J Pain Symptom Manage 28 2004 72 91
15. M.R. Semenchuk, S. Sherman, B. Davis Double-blind randomized trial of bupropion SR for the treatment of neuropathic pain Neurology 57 2001 1583 1588
16. T.O. Staiger, B. Gaster, M.D. Sullivan, R. Deyo Systematic review of antidepressants in the treatment of chronic low back pain Spine 28 2003 2540 2545
17. D.C. Turk, R.H. Dworkin, R.R. Allen, N. Bellamy, N. Brandenburg, D.B. Carr, C. Cleeland, R. Dionne, J.T. Farrar, B.S. Galer, D.J. Hewitt, A.R. Jadad, N.P. Katz, L.D. Kramer, D.C. Manning, C.G. McCormick, M.P. McDermott, P. McGrath, S. Quessy, B.A. Rappaport, J.P. Robinson, M.A. Royal, L. Simon, J.W. Stauffer, W. Stein, J. Tollett, J. Witter Core outcome domains for chronic pain clinical trials IMMPACT recommendations Pain 106 2003 337 345